Latest News

LaRDR Annual Investigator Meeting – co-hosted with the Australasian Lymphoma Alliance (ALA)

We will provide progress updates on the work of both LaRDR and the ALA, as well as news on completed, ongoing, and planned projects. It will be a great opportunity to meet and discuss and plan to collaborate for the future.
Program details:

  • Welcome/introduction
  • Overview of LaRDR and ALA
  • Project updates
  • Discussion

Registrations close on the 24th of November at 2 pm. This event will be live-streamed and the link will be sent to you shortly after registration closes.

For further information please contact LaRDR on sphpm-lymphoma@monash.edu

What is LaRDR?

The Lymphoma and Related Diseases Registry (LaRDR) is an Australasian initiative to improve the treatment and outcomes of patients with lymphoma.

The LaRDR is managed by Monash University’s School of Public Health and Preventive Medicine, through the Transfusion Research Unit, which manages a number of other clinical registries for important blood disorders.

The registry will include all new cases of Hodgkin and non-Hodgkin lymphomas at registered hospital sites.   National representative data on diagnosis and treatment will be collected, allowing the LaRDR team to

  • Understand access to care
  • Monitor trends in practice, outcomes and survival
  • Explore variation in factors that influence outcomes including survival and quality of life
  • Benchmark outcomes nationally and internationally
  • Act as a resource for clinical trials

Highlights

icon1-02
0

Estimated number of new cases of Lymphoma diagnosed in Australia in 2019

icon3-02
0

Estimated number of deaths from Lymphoma in Australia in 2019

icon2-02
0%

Chance of surviving Leukaemia in Australia for at least 5 years (2009-2013)

Source: Australian Institute of Health and Welfare. (2019). Cancer in Australia 2019. Canberra: AIHW.

https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2019